Find information on thousands of medical conditions and prescription drugs.

Kawasaki syndrome

Kawasaki disease, also known as mucocutaneous lymph node syndrome, mucocutaneous lymph node disease, infantile polyarteritis and Kawasaki syndrome, is a poorly-understood non-contagious illness that affects the mucous membranes, lymph nodes, blood vessel walls, and the heart. It was first described in 1967 by Dr. Tomisaku Kawasaki. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
Kallmann syndrome
Kallmann syndrome
Kallmann syndrome
Kallmann syndrome
Kaposi sarcoma
Karsch Neugebauer syndrome
Kartagener syndrome
Kawasaki syndrome
Kearns-Sayre syndrome
Keloids
Kennedy disease
Keratoacanthoma
Keratoconjunctivitis sicca
Keratoconus
Keratomalacia
Keratosis pilaris
Kernicterus
Kikuchi disease
Klinefelter's Syndrome
Klippel Trenaunay Weber...
Klippel-Feil syndrome
Klumpke paralysis
Kluver-Bucy syndrome
Kniest dysplasia
Kocher-Debré-Semélaigne...
Kohler disease
Korsakoff's syndrome
Kostmann syndrome
Kyphosis
Seborrheic keratosis
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Incidence, causes, and risk factors

Kawasaki disease occurs mainly in Japan, though its incidence in the United States is increasing. Kawasaki disease is predominantly a disease of young children, with 80% of patients younger than 5 years of age, but no other contributing factors are known.

The causative agent of Kawasaki disease is still unknown. But current etiological theories center on immunological causes for the disease. Much research is being performed to discover a definitive toxin or antigenic substance, possibly a superantigen, that is the specific cause of the disease.

The cardiac involvement and complications are, by far, the most important aspect of the disease. Kawasaki disease can cause vasculitis (inflammation of blood vessels) in the coronary arteries and subsequent coronary artery aneurysms. These aneurysms can lead to myocardial infarction (heart attack) even in young children (rarely). About 20–40% of children with Kawasaki disease will have evidence of vasculitis with cardiac involvement.

Kawasaki disease often begins with a high and persistent fever that is not very responsive to normal doses of acetaminophen or ibuprofen. The fever may persist steadily for up to two weeks. The children develop red eyes, red mucous membranes in the mouth, red cracked lips, a "strawberry tongue" and swollen lymph nodes. Skin rashes may occur early in the disease and peeling of the skin in the genital area, hands, and feet (especially around the nails and on the palms and soles) may occur.

Symptoms

  • High-grade fever (greater than 39 °C or 102 °F; often as high as 40 °C or 104 °F) that is unresponsive to medication and lasts more than three days (persistent fever lasting at least five days is considered a hallmark sign)
  • Extremely bloodshot or red eyes (conjunctivitis without pus or drainage)
  • Bright red, chapped, or cracked lips
  • Red mucous membranes in the mouth
  • Strawberry tongue, white coating on the tongue or prominent red bumps (papillae) on the back of the tongue
  • Red palms of the hands and the soles of the feet
  • Swollen hands and feet
  • Peeling palms and soles (later in the illness); peeling may begin around the nails
  • Rashes similar to erythema multiforme (rash, NOT blister-like, on the trunk)
  • Swollen lymph nodes (frequently only one lymph node is swollen), particularly in the neck area
  • Joint pain (arthralgia) and swelling, frequently symmetrical

Signs and tests

A physical examination will demonstrate many of the symptoms listed above. Procedures such as ECG and echocardiography may reveal signs of myocarditis, pericarditis, arthritis, aseptic meningitis, and coronary vasculitis.

Read more at Wikipedia.org


[List your site here Free!]


Kawasaki syndrome - Children in Hospitals …
From Pediatrics for Parents, 5/1/03 by John E. Monaco

Having recently cared for a child with this exotic sounding disease, I thought it might be interesting for parents to know a little more about it.

As with many pediatric diseases with unusual names, parents' initial reaction to hearing this diagnostic possibility for their child is immense anxiety--yet another example of fearing that which one does not understand.

In the case of Kawasaki Syndrome (KS), it is not as uncommon as one might think. In the US, the overall incidence is approximately 10 per 100,000. It is the leading cause of acquired pediatric heart disease. KS tends to most commonly affect children under 5 years of age, but is rare in children under about a year old. Now that treatment options are better understood, mortality is low, but many children can become quite ill from this disorder and it may require a prolonged convalescence.

Just what is KS? As one might expect, it was first described in the medical literature by Dr. Kawasaki in Japan. He noticed a group of children who developed coronary artery disease, including some deaths from myocardial infarctions (heart attacks), several weeks after recovering from a flu-like illness. As he looked into it more closely, he realized that many of the children with this illness had very similar signs and symptoms which could not be explained by any other illness.

As doctors around the world learned about this association, they began to pool their experiences, eventually defining specific criteria for making the diagnosis of KS.

To be diagnosed with KS, a child must first have fever for 5 days that is not explained by any other infection. Then, they must have at least four of the following five signs, none of which can be explained by any other infection:

1. Puffiness of the hands and feet

2. A characteristic rash over the trunk and extremities

3. Conjunctivits (inflammation of the whites of the eyes)

4. Redness and swelling of the lips and tongue

5. At least one enlarged neck lymph node.

Obviously, these findings are somewhat nonspecific, so other illness must be eliminated as possible cause before a diagnosis of KS can be made. These include measles, Rocky Mountain Spotted Fever, Scarlet Fever, Toxic Shock Syndrome, Juvenile Rheumatoid Arthritis and Epstein-Barr Virus infection.

Why is the diagnosis of KS so important? This is the crux the matter. If undiagnosed and therefore untreated, there is a 1 in 5 chance that the child will develop an aneurysm (weaknesses in the wall of a vessel that can lead to bulging and even rupture) of one or more of the coronary arteries. This may lead to myocardial infarction and/or death. If instituted in time, the treatment can completely eliminate the possibility of this.

So what is the treatment? There are two phases. One involves the use of aspirin which decrease the fever and inflammation as well as decreasing the "stickiness" of platelets. This component of the blood plays a role in the development of coronary aneurysms.

The parents of the last KS patients I treated with aspirin raised concern over the possibility of Reye's syndrome. This is mainly a theoretic possibility and has not been reported to any significant degree. Besides, the risk of not treating for KS is far greater than the remote possibility of this complication.

The second and perhaps most important phase of treatment involves the use of intravenous gammaglobulin (IVIG) which acts primarily to quiet down what seems to be an out of control immune response. Usually after one, and sometimes two, doses of IVIG, the child's symptoms abate, and the risk of cardiac complications is essentially eliminated.

The exact cause of KS is not yet known, but it is felt to be due to an as yet unidentified infectious agent, an unknown bacteria or virus. The resulting inflammatory response from this infection results in vasculitis (inflammation of the walls of blood vessels) that affects every organ system to some degree. The blood vessels supplying the heart seem to be particularly vulnerable.

So, when your child has a seemingly unrelenting fever for five days, as well as some of the other symptoms listed above, your child's doctor may begin to consider the possibility of Kawasaki Syndrome. Don't be overly alarmed if he does. Although not everything is yet known about this disorder, enough is understood to enable doctors to protect your child from the potential long term ill effects of this curious disease.

John E. Monaco, M.D., is board certified in both Pediatrics and Pediatric Critical Care. He lives and works in Tampa, Florida. He welcomes your comments, suggestions, and criticisms.

COPYRIGHT 2003 Pediatrics for Parents, Inc.
COPYRIGHT 2003 Gale Group

Return to Kawasaki syndrome
Home Contact Resources Exchange Links ebay